Millennium partners with Presage on solid tumour combo drugs
This article was originally published in Scrip
Executive Summary
The US biotech Presage Biosciences touts itself as being able to provide drug makers with tools and technology that can aid in the comparison of multiple cancer drug candidates and drug combinations within the same single living tumour.